Published January 30, 2018
Point-of-care testing is medical diagnostic testing or near point-of-care testing. Point-of-care tests are simple medical tests that are performed and develop new technology to mask the complexity. Connectivity is an important part of the point-of-care market.
Asia-Pacific Point-of-care Diagnostic Market Segments size & growth:
The market is valued at $ 2.603 billion in 2017 and is projected to $ 4.344 billion by 2024 at a CAGR of 9.9%. The significant factors that are driving the growth of the market are an increase in awareness and inclination towards home health care, and prevalence of lifestyle and infectious disease and demand for the market is expected to grow in the further years. Rapid growth in ageing population, advancements in technology and increase in some chronic diseases.
Asia-Pacific Point-of-care Diagnostic Market Share:
Point-of-care diagnostics market is categorised by by-product, mode of delivery and end user. By by-product, it is segmented into infectious disease, glucose monitoring kit, oncology markers, coagulation, drugs of abuse and blood gas testing and others. Based on the mode of delivery the market is categorised into OTC testing and prescription. And based on end users the market is segmented into research laboratories, home health care, and hospitals. As by-product categorises the market, mode of delivery and end user the market equally constitutes the market share in all the categories like hospitals, research laboratories and home health care, testing and monitoring. Geographically, Asia-Pacific is a fastest growing segment and exhibit strong growth rate during the forecast (2018-24)
Asia-Pacific Point-of-care Diagnostic Market Trends:
Asia-Pacific Point-of-care Diagnostic Market Research Reports Include:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players are:
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.4 SWOT Analysis
3.5 Y-O-Y Analyses
4 Market Dynamics
4.1.1 Increasing prevalence of chronic and infectious diseases.
4.1.2 Initiatives implemented by government and not-for-profit associations for rising health awareness.
4.1.3 Technological advancements and adoption of a home-based point of care devices and new product launches.
4.1.4 Increase in worldwide expenditures on healthcare.
4.1.5 Increase in usage of home-based POC devices due to the shortage of skilled laboratory technicians.
4.2.1 Lack of coordination among organisations (healthcare).
4.2.2 High procedure costs.
4.2.3 Inadequate reimbursement policies for point of care diagnostics devices.
4.2.4 Product prices and hampering profits.
4.2.5 Time-consuming policies, therefore, increasing gestation period for product launches.
4.3.1 Miniaturization of testing devices.
4.3.2 Developing economies after lucrative growth opportunities and increasing number of conferences and events.
4.4.1 Irresponsible towards the change of treatment practices.
4.4.2 Lack of professionals and lack of knowledge on POC devices.
5 Asia-Pacific Point of Care Diagnostics Market – By Product
5.2 Infectious diseases
5.3 Cardio metabolic kits
5.4 Glucose monitoring kits
5.5 Oncology markers
5.8 OTC diagnostics test
5.9 Drugs of abuse
5.10 Blood gas testing
5.11 Fertility testing
6 Asia-Pacific Point of Care Diagnostics Market – By mode of delivery
6.2 OTC testing
7 Point of Care Diagnostics Market – By End-user
7.3 Research laboratories
7.4 Home healthcare
8 Asia-Pacific Point of Care Diagnostics Market – By Geography
9 Asia-Pacific Point of Care Diagnostics – Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
10 Asia-Pacific Point of Care Diagnostics – Company Profiles
10.1 Abbott laboratories
10.2 Siemens AG
10.3 Dickinson and company
10.4 PTS diagnostics
10.5 Nova biomedical
10.7 Alere Inc.
10.9 Beckman Coulter, Inc.
10.10 Johnson & Johnson Services Inc
10.11 Instrumentation laboratory
11 Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12.1 List of Tables
12.2 List of Figures